Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type (Instruments and Reagents and Kits), By Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NASBA), Transcription Medicated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), By Application (Infectious Disease Diagnostics, Blood Screening, and Others), By End User (Academic and Research Institutes, Diagnostic Laboratories, and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023

Code : CMI2831

Pages :177

Formats :

Excel and PDF

Industry : Biotechnology

Market News

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market- Key Developments

In May 2022, Hologic, Inc. is a medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging., received CE marking for two new molecular assays named Panther Fusion EBV Quant Assay and Panther Fusion BKV Quant Assay, expanding its transplant pathogen monitoring product portfolio on the Panther Fusion system.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market- Key Trends

Increasing Product Launches

Increasing product launch of loop-mediated isothermal amplification for the isothermal nucleic acid amplification technology is expected to drive the global isothermal nucleic acid amplification technology market growth over the forecast period. For instance, in May 2022, Meridian Bioscience is a life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products., launched two new innovative isothermal amplification products named Lyo-Ready Direct DNA LAMP Saliva Mix and Lyo-Ready Direct RNA/DNA LAMP saliva mix. These are used for direct detection of DNA and RNA in point of care dagnostics assays.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global isothermal nucleic acid amplification technology (INAAT) market growth, owing to increasing usage of and product approvals and launches of isothermal nucleic acid amplification technology during the pandemic. For instance, in March 2020, Abbott company provides from newborns to aging adults, from nutrition and diagnostics through medical care and pharmaceutical therapy. , received the U.S. Food and Drug Administration approval for the emergency use of ID NOW COVID-19, an instrument-based, isothermal, rapid system for the qualitative finding of disease.